ロード中...
Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer
OBJECTIVES: We previously reported the feasibility of neoadjuvant capecitabine and oxaliplatin plus bevacizumab as a treatment for locally advanced rectal cancer (UMIN000003219). The aim of this study is to investigate the prognostic relevance of neoadjuvant chemotherapy followed by total mesorectal...
保存先:
| 出版年: | J Anus Rectum Colon |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japan Society of Coloproctology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7390618/ https://ncbi.nlm.nih.gov/pubmed/32743112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23922/jarc.2019-042 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|